Sophie Gillette
University of Toulouse
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sophie Gillette.
Journal of the American Geriatrics Society | 2004
Sylvie Lauque; Franck Arnaud-Battandier; Sophie Gillette; Jean-Marie Plaze; Sandrine Andrieu; Christelle Cantet; Bruno Vellas
Objectives: To study the effects of oral nutritional supplements (OS) on body weight, body composition, nutritional status, and cognition in elderly patients with Alzheimers disease (AD).
Medical Clinics of North America | 2011
Yves Rolland; Charlotte Dupuy; Gabor Abellan van Kan; Sophie Gillette; Bruno Vellas
Sarcopenia is the key feature of frailty in older people and a major determinant of adverse health outcomes such as functional limitations and disability. Resistance training and adequate protein and energy intake are the key strategies for the management of sarcopenia. Management of weight loss and resistance training are the most relevant protective countermeasures to slow down the decline of muscle mass and muscle strength. The quality of amino acids in the diet is an important factor for stimulating protein synthesis. Vitamin D deficiency should be treated, and new pharmacologic approaches for sarcopenia are currently assessed.
Health Economics Review | 2012
Nagede Costa; Hélène Derumeaux; Thomas Rapp; Valérie Garnault; Laura Ferlicoq; Sophie Gillette; Sandrine Andrieu; Bruno Vellas; Michel Lamure; Alain Grand; Laurent Molinier
Cost-of-illness studies (COI) can identify and measure all the costs of a particular disease, including the direct, indirect and intangible dimensions. They are intended to provide estimates about the economic impact of costly disease. Alzheimer disease (AD) is a relevant example to review cost of illness studies because of its costliness.The aim of this study was to review relevant published cost studies of AD to analyze the method used and to identify which dimension had to be improved from a methodological perspective. First, we described the key points of cost study methodology. Secondly, cost studies relating to AD were systematically reviewed, focussing on an analysis of the different methods used. The methodological choices of the studies were analysed using an analytical grid which contains the main methodological items of COI studies. Seventeen articles were retained. Depending on the studies, annual total costs per patient vary from
Journal of Nutrition Health & Aging | 2013
Charlotte Dupuy; Valérie Lauwers-Cancès; G. Abellan Van Kan; Sophie Gillette; Anne-Marie Schott; O. Beauchet; C. Annweiler; Bruno Vellas; Yves Rolland
2,935 to
International Journal of Geriatric Psychiatry | 2013
Hélène Villars; Charlotte Dupuy; Pauline Soler; Virginie Gardette; Maria Soto; Sophie Gillette; Fati Nourhashemi; BrunoVellas
52, 954. The methods, data sources, and estimated cost categories in each study varied widely. The review showed that cost studies adopted different approaches to estimate costs of AD, reflecting a lack of consensus on the methodology of cost studies. To increase its credibility, closer agreement among researchers on the methodological principles of cost studies would be desirable.
Journals of Gerontology Series A-biological Sciences and Medical Sciences | 2003
Sandrine Andrieu; Sophie Gillette; Karine Amouyal; Fati Nourhashemi; Emma Reynish; Pierre Jean Ousset; Jean Louis Albarede; Bruno Vellas; Hélène Grandjean
ObjectivesVitamin D intake may prevent physical performance decline through prevention of muscle mass loss. Our objective was to determine whether low dietary intakes were associated with low muscle mass (MM).Design and participantsCross-sectional analysis of 1989 community-dwelling women (mean age 80.5±3.8years) from the EPIDémiologie de l’OStéoporose (EPIDOS) study were assessed at baseline.MeasurementsLow intakes of vitamin D (<70µg/week) were estimated from the weekly dietary vitamin D intakes (self-administered food frequency questionnaire). Low MM was defined according to the appendicular skeletal muscle mass index assessed using Dual Energy X-ray Absorptiometry, divided by square height of less than 5.45 kg/m2. Usual gait speed defined physical performance. Age, sun exposure, co-morbidities, education level, living arrangements, recreational physical activity, dietary protein and calcium intakes, bone mineral density, handgrip strength, and body mass index were considered as potential confounders. Multivariate logistic regression analyses assessed the association between low vitamin D intakes and low MM.ResultsTwo-hundred and nine (10.5%) women with low MM were compared to 1,780 women with normal MM. In final model, obesity/overweight (Adjusted Odds Ratios, aOR=0.09; 95%CI [0.05–0.17]), malnutrition (aOR=3.90; 95%CI [2.74–5.54]) and low handgrip strength (aOR=2.33; 95%CI [1.44–3.77]; p<0.001) were statistically associated with a low MM status.ConclusionNo association with low MM has been reported regarding low dietary intakes of vitamin D.
American Journal of Cardiovascular Drugs | 2013
Neda Tavassoli; Amélie Perrin; Emilie Bérard; Sophie Gillette; Bruno Vellas; Yves Rolland
Emergency room (ER) re‐hospitalizations are prevalent in severe Alzheimers disease affected older patients.
La Revue du praticien | 2005
Fati Nourhashemi; Sophie Gillette; Sandrine Andrieu
Alzheimers & Dementia | 2011
Julien Delrieu; Pierre Payoux; Anne Hitzel; Sophie Peiffer; Gabor Abellan van Kan; Sophie Gillette; Andrieu Sandrine; Bruno Vellas
Alzheimers & Dementia | 2009
Sophie Gillette